Demand for at-home sample collection and infectious disease testing is at an all-time high—and still growing.
Recent developments suggest that we are on the precipice of a new age offering expanded options for Alzheimer’s diagnosis.
Researchers find that three out of four blood tests produced different results depending on if they were used for White or Black people.
Even when accounting for the impact of COVID-19, recent report suggests the future of direct-to-consumer genetic testing remains bright.
Research team creates a promising new mass spectrometry-based blood lipid test.